Edwards Lifesciences Common stock, shares issued (in shares) increased by 0.2% to 660M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from 655.9M to 660M. Over 5 years (FY 2020 to FY 2025), Common stock, shares issued (in shares) shows relatively stable performance with a 0.7% CAGR.
An increase indicates equity issuance, while a decrease (rare) would indicate share cancellations.
The total number of shares that have been sold or distributed to shareholders since the company's inception. This includ...
Standard corporate governance metric; comparable to 'Issued Shares' at any public company.
other_common_stock_shares_issued| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 640.1M | 641.2M | 642M | 642.9M | 645M | 645.7M | 646.3M | 647.1M | 649.1M | 649.9M | 650.5M | 651.8M | 653.5M | 654.3M | 654.8M | 655.9M | 657.6M | 658.2M | 658.7M | 660M |
| QoQ Change | — | +0.2% | +0.1% | +0.1% | +0.3% | +0.1% | +0.1% | +0.1% | +0.3% | +0.1% | +0.1% | +0.2% | +0.3% | +0.1% | +0.1% | +0.2% | +0.3% | +0.1% | +0.1% | +0.2% |
| YoY Change | — | — | — | — | +0.8% | +0.7% | +0.7% | +0.7% | +0.6% | +0.7% | +0.6% | +0.7% | +0.7% | +0.7% | +0.7% | +0.6% | +0.6% | +0.6% | +0.6% | +0.6% |